Abiopharma

Cline Darren S 🟢 acquired 60.0K shares (2 derivative) of Xenon Pharmaceuticals Inc. (XENE) at $42.15 ($1.7M) Transaction Date: Jan 09, 2026 | Filing ID: 009235

DiFabio Andrea 🟢 acquired 95.0K shares (2 derivative) of Xenon Pharmaceuticals Inc. (XENE) at $42.15 ($3.4M) Transaction Date: Jan 09, 2026 | Filing ID: 009232

MORTIMER IAN 🟢 acquired 415.0K shares (2 derivative) of Xenon Pharmaceuticals Inc. (XENE) at $42.15 ($14.8M) Transaction Date: Jan 09, 2026 | Filing ID: 009230

Watson David O. 🟡 adjusted position in 0 shares (1 derivative) of Apellis Pharmaceuticals, Inc. (APLS) at $14.95 Transaction Date: Jan 07, 2026 | Filing ID: 000017

Edwards Lifesciences Corp - Edwards Comments on JenaValve Acquisition

Edwards Comments on JenaValve Acquisition

ResMed Inc. Daily Stock Update

New Form 3 - Bausch & Lomb Corp Filed: 2026-01-09 AccNo: 0001860742-26-000003 Size: 6 KB

New Form 3 - EDAP TMS SA Filed: 2026-01-09 AccNo: 0001829126-26-000191 Size: 11 KB

New Form 3 - EDAP TMS SA Filed: 2026-01-09 AccNo: 0001829126-26-000190 Size: 12 KB

Coastal Financial Corporation Acquires GreenFi Brand, Expanding Strategic Flexibility

New Form SCHEDULE 13G/A - Forte Biosciences, Inc. Filed: 2026-01-09 AccNo: 0001376474-26-000030 Size: 7 KB

New Form 3 - BRUKER CORP Filed: 2026-01-09 AccNo: 0001784805-26-000005 Size: 3 KB

Garland J. Scott 🟢 acquired 59.4K shares (1 derivative) of Enliven Therapeutics, Inc. (ELVN) at $15.47 Transaction Date: Jan 07, 2026 | Filing ID: 000002

New Form 3 - Enliven Therapeutics, Inc. Filed: 2026-01-09 AccNo: 0001533228-26-000001 Size: 10 KB